Overall rank by patents
#24,279
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Elekta AB
USPTO PatentsView assignee record - 11 granted patents across 14 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
11
Total patents granted
14
CPC technology areas
17.8
Avg claims per patent
-62%
5-year filing velocity
The verdict
Elekta holds 11 US patents across 14 technology areas, rank #24,279 of 50,000 tracked assignees.
- #24,279
- of 50,000 US assignees by volume
- Top 51%
- by Innovation Score (34.7/100)
- 17.8
- avg claims per patent
- -62%
- filing velocity, last 5 yrs
Portfolio overview
Elekta AB has been granted 11 US utility patents between 2015 and 2022, placing Elekta AB at rank #24,279 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.8 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Elekta AB is one of the more focused assignees in the PatentsView dataset. By volume, Elekta sits between Egg Medical, Inc. (11 patents, rank #24,275) and Emendobio Inc. (11 patents, rank #24,283) - the closest US assignees by grant volume. The composite Innovation Score of 34.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 8 in the 2015–2019 window, a -62% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Elekta AB's 17.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Elekta AB against peers pursuing similar technology classes.
Who files at Elekta's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Egg Medical
Egg Medical, Inc.
11 patents
- Egress Software IP
Egress Software Technologies IP Limited
11 patents
- Electratherm
ElectraTherm, Inc.
11 patents
- Electric Torque M…
Electric Torque Machines, Inc.
11 patents
- Elemental Machines
Elemental Machines, Inc.
11 patents
- Eleven Street
Eleven Street Co., Ltd.
11 patents
- Embodied Intellig…
Embodied Intelligence Inc.
11 patents
- Emendobio
EmendoBio Inc.
11 patents
- Elekta AB ◀
Elekta AB
11 patents
What this shows Elekta holds 11 patents at rank #24,279, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Elekta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 51% higher than 49% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 1 | 9.1% |
| 2017 | 2 | 18.2% |
| 2018 | 2 | 18.2% |
| 2019 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2022 | 1 | 9.1% |
Which technologies does Elekta AB patent most?
Top 14 of 14 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Elekta AB hold?
Elekta AB holds 11 US granted patents filed between 2015 and 2022, spanning 14 technology areas.
What is Elekta AB's Innovation Score?
Elekta AB has an Innovation Score of 34.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Elekta AB focus on?
Elekta AB's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 8 patents. The company has filed patents in 14 CPC subclasses total.
Is Elekta AB's patent filing rate increasing or decreasing?
Elekta AB's recent filing velocity is -62% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Elekta AB's patents?
Elekta AB's patents average 17.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Elekta AB patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Elekta's 11 grants land it in the top 51% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Elekta ranks #24,279 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.